Perineural dexmedetomidine added to ropivacaine causes a dose-dependent increase in the duration of thermal antinociception in sciatic nerve block in rat

Anesthesiology

Volumn 111, Issue 5, 2009, Pages 1111-1119

  Brummett, Chad M ^a   Padda, Amrita K ^b   Amodeo, Francesco S ^b   Welch, Kathleen B ^c   Lydic, Ralph ^b  

^a Division of Pain Medicine

^b Department of Anesthesiology ^*

^c UNIVERSITY OF MICHIGAN   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

DEXMEDETOMIDINE; ROPIVACAINE;

ADD ON THERAPY; ANALGESIA; ANIMAL EXPERIMENT; ANTINOCICEPTION; ARTICLE; CLINICAL ASSESSMENT; CONTROLLED STUDY; DOSE RESPONSE; DRUG EFFICACY; DRUG MEGADOSE; LATENT PERIOD; MALE; MOTOR PERFORMANCE; NERVE BLOCK; NEUROTOXICITY; NONHUMAN; PAW EDEMA; PERINEURIUM; PRIORITY JOURNAL; RAT; SCIATIC NERVE; SENSORY NERVE; THERMAL STIMULATION; WITHDRAWAL REFLEX;

EID: 70350461546     PISSN: 00033022     EISSN: 15281175     Source Type: Journal    
DOI: 10.1097/ALN.0b013e3181bbcc26     Document Type: Article

References (48)

1. Casati A, Fanelli G, Albertin A, Deni F, Anelati D, Antonino FA, Beccaria P: Interscalene brachial plexus anesthesia with either 0.5% ropivacaine or 0.5% bupivacaine. Minerva Anestesiol 2000; 66:39-44
2. Hickey R, Hoffman J, Ramamurthy S: A comparison of ropivacaine 0.5% and bupivacaine 0.5% for brachial plexus block. ANESTHESIOLOGY 1991; 74:639-642
3. Hickey R, Rowley CL, Candido KD, Hoffman J, Ramamurthy S, Winnie AP: A comparative study of 0.25% ropivacaine and 0.25% bupivacaine for brachial plexus block. Anesth Analg 1992; 75:602-606
4. Vaghadia H, Chan V, Ganapathy S, Lui A, McKennaJ, Zimmer K: A multicentre trial of ropivacaine 7.5 mg X ml-1 versus bupivacaine 5 mg X ml-1 for supra clavicular brachial plexus anesthesia. Can J Anaesth 1999; 46:946-951
5. Lydic R, Baghdoyan HA: Neurochemical mechanisms mediating opioid-induced REM sleep disruption, Sleep and Pain. Edited by Lavigne G, Sessle BJ, Choinère M, Soja PJ. Seattle, International Association for the Study of Pain Press, 2007, pp 99-122
6. Bonafide CP, Aucutt-Walter N, Divittore N, King T, Bixler EO, Cronin AJ: Remifentanil inhibits rapid eye movement sleep but not the nocturnal melatonin surge in humans. ANESTHESIOLOGY 2008; 108:627-633
7. Bowdle TA: Nocturnal arterial oxygen desaturation and episodic airway obstruction after ambulatory surgery. Anesth Analg 2004; 99:70-76
8. Rosenberg J, Rosenberg-Adamsen S, Kehlet H: Post-operative sleep disturbance: Causes, factors and effects on outcome. Eur J Anaesthesiol Suppl 1995; 10:28-30
9. Eisenach JC, De Kock, M Klimscha W: a2-Adrenergic agonists for regional anesthesia: A clinical review of clonidine (1984-1995). ANESTHESIOLOGY 1996; 85:655-674
10. Murphy DB, McCartney CJ, Chan VW: Novel analgesic adjuncts for brachial plexus block: A systematic review. Anesth Analg 2000; 90:1122-1128
11. McCartney CJ, Duggan E, Apatu E: Should we add clonidine to local anesthetic for peripheral nerve blockade? A qualitative systematic review of the literature. Reg Anesth Pain Med 2007; 32:330-338
12. Brummett CM, Norat MA, Palmisano JM, Lydic R: Perineural administration of dexmedetomidine in combination with bupivacaine enhances sensory and motor blockade in sciatic nerve block without inducing neurotoxicity in rat. ANESTHESIOLOGY 2008; 109:502-511
13. Chazalon P, Tourtier JP, Villevielle T, Giraud D, Saissy JM, Mion G, Ben-hamou D: Ropivacaine-induced cardiac arrest after peripheral nerve block: Successful resuscitation. ANESTHESIOLOGY 2003; 99:1449-1451
14. Polley LS, Santos AC: Cardiac arrest following regional anesthesia with ropivacaine: Here we go again! ANESTHESIOLOGY 2003; 99:1253-1254
15. Ohmura S, Kawada M, Ohta T, Yamamoto K, Kobayashi T: Systemic toxicity and resuscitation in bupivacaine-, levobupivacaine-, or ropivacaine-in-fused rats. Anesth Analg 2001; 93:743-748
16. Klein SM, Pierce T, Rubin Y, Nielsen KC, Steele SM: Successful resuscitation after ropivacaine-induced ventricular fibrillation. Anesth Analg 2003; 97: 901-903
17. Cederholm I, Evers H, Lofstrom JB: Skin blood flow after intradermal injection of ropivacaine in various concentrations with and without epinephrine evaluated by laser Doppler flowmetry. Reg Anesth 1992; 17:322-328
18. Dahl JB, Simonsen L, Mogensen T, Henriksen JH, Kehlet H: The effect of 0.5% ropivacaine on epidural blood flow. Acta Anaesthesiol Scand 1990; 34: 308-310
19. Hargreaves K, Dubner R, Brown F, Flores C, Joris J: A new and sensitive method for measuring thermal nociception in cutaneous hyperalgesia. Pain 1988; 32:77-88
20. Dirig DM, Salami A, Rathbun ML, Ozaki GT, Yaksh TL: Characterization of variables defining hindpaw withdrawal latency evoked by radiant thermal stimuli. J Neurosci Methods 1997; 76:183-191
21. Gerner P, Luo SH, Zhuang ZY, Djalali AG, Zizza AM, Myers RR, Wang GK: Differential block of N-propyl derivatives of amitriptyline and doxepin for sciatic nerve block in rats. Reg Anesth Pain Med 2005; 30:344-350
22. Hung YC, Kau YC, Zizza AM, Edrich T, Zurakowski D, Myers RR, Wang GK, Gerner P: Ephedrine blocks rat sciatic nerve in vivo and sodium channels in vitro. ANESTHESIOLOGY 2005; 103:1246-1252
23. Kau YC, Hung YC, Zizza AM, Zurakowski D, Greco WR, Wang GK, Gerner P: Efficacy of lidocaine or bupivacaine combined with ephedrine in rat sciatic nerve block. Reg Anesth Pain Med 2006; 31:14-18
24. Dyhre H, Soderberg L, Bjorkman S, Carlsson C: Local anesthetics in lipid-depot formulations: Neurotoxicity in relation to duration of effect in a rat model. Reg Anesth Pain Med 2006; 31:401-408
25. Soderberg L, Dyhre H, Roth B, Bjorkman S: Ultralong peripheral nerve block by lidocaine:prilocaine 1:1 mixture in a lipid depot formulation: Comparison of in vitro, in vivo, and effect kinetics. ANESTHESIOLOGY 2006; 104: 110-121
26. Kytta J, Heinonen E, Rosenberg PH, Wahlstrom T, Gripenberg J, Huopani-emi T: Effects of repeated bupivacaine administration on sciatic nerve and surrounding muscle tissue in rats. Acta Anaesthesiol Scand 1986; 30:625-629
27. Pere P, Watanabe H, Pitkanen M, Wahlstrom T, Rosenberg PH: Local myotoxicity of bupivacaine in rabbits after continuous supraclavicular brachial plexus block. Reg Anesth 1993; 18:304-307
28. Allison PD: Estimating Cox regression models with PROC PHREG, Survival Analysis Using SAS: A Practical Guide. Edited by Allison PD, Cary NC, SAS Publishing, 1995, pp 111-184
29. Ramsay MA, Luterman DL: Dexmedetomidine as a total intravenous anesthetic agent. ANESTHESIOLOGY 2004; 101:787-790
30. Martin E, Ramsay G, Mantz J, Sum-Ping ST: The role of the alpha2-adrenoceptor agonist dexmedetomidine in postsurgical sedation in the intensive care unit. J Intensive Care Med 2003; 18:29-41
31. Ramsay MA, Saha D, Hebeler RF: Tracheal resection in the morbidly obese patient: The role of dexmedetomidine. J Clin Anesth 2006; 18:452-454
32. Venn RM, Grounds RM: Comparison between dexmedetomidine and propofol for sedation in the intensive care unit: Patient and clinician perceptions. Br J Anaesth 2001; 87:684-690
33. Butterworth JF, Strichartz GR: The alpha 2-adrenergic agonists clonidine and guanfacine produce tonic and phasic block of conduction in rat sciatic nerve fibers. Anesth Analg 1993; 76:295-301
34. Dalle C, Schneider M, Clergue F, Bretton C, Jirounek P: Inhibition of the Ih current in isolated peripheral nerve: A novel mode of peripheral antinociception? Muscle Nerve 2001; 24:254-261
35. Gaumann DM, Brunet PC, Jirounek P: Hyperpolarizing afterpotentials in C fibers and local anesthetic effects of clonidine and lidocaine. Pharmacology 1994; 48:21-29
36. Starke K, Wagner J, Schumann HJ: Adrenergic neuron blockade by clonidine: Comparison with guanethidine and local anesthetics. Arch Int Phar-macodyn Ther 1972; 195:291-308
37. Pape HC: Queer current and pacemaker: The hyperpolarization-activated cation current in neurons. Annu Rev Physiol 1996; 58:299-327
38. Singelyn FJ, Gouverneur JM, Robert A: A minimum dose of clonidine added to mepivacaine prolongs the duration of anesthesia and analgesia after axillary brachial plexus block. Anesth Analg 1996; 83:1046-1050
39. Lavand'homme PM, Eisenach JC: Perioperative administration of the al-pha2-adrenoceptor agonist clonidine at the site of nerve injury reduces the development of mechanical hypersensitivity and modulates local cytokine expression. Pain 2003; 105:247-254
40. Romero-Sandoval A, Eisenach JC: Perineural clonidine reduces mechanical hypersensitivity and cytokine production in established nerve injury. ANESTHESIOLOGY 2006; 104:351-355
41. Romero-Sandoval A, Eisenach JC: Clonidine reduces hypersensitivity and alters the balance of pro-and anti-inflammatory leukocytes after local injection at the site of inflammatory neuritis. Brain Behav Immun 2007; 21:569-580
42. Romero-Sandoval EA, McCall C, Eisenach JC: Alpha2-adrenoceptor stimulation transforms immune responses in neuritis and blocks neuritis-induced pain. J Neurosci 2005; 25:8988-8994
43. Carollo DS, Nossaman BD, Ramadhyani U: Dexmedetomidine: A review of clinical applications. Curr Opin Anaesthesiol 2008; 21:457-461
44. Dyhre H, Lang M, Wallin R, Renck H: The duration of action of bupivacaine, levobupivacaine, ropivacaine and pethidine in peripheral nerve block in the rat. Acta Anaesthesiol Scand 1997; 41:1346-1352
45. Simpson D, Curran MP, Oldfield V, Keating GM: Ropivacaine: A review of its use in regional anaesthesia and acute pain management. Drugs 2005; 65:2675-2717 (Pubitemid 43050960)
46. Hansen TG: Ropivacaine: A pharmacological review. Expert Rev Neu-rother 2004; 4:781-791
47. Zink W, Graf BM: Benefit-risk assessment of ropivacaine in the management of postoperative pain. Drug Saf 2004; 27:1093-1114
48. Gaumann DM, Brunet PC, Jirounek P: Clonidine enhances the effects of lidocaine on C-fiber action potential. Anesth Analg 1992; 74:719-725